2A Pharma ApS: Financial statements 2020
CVR: 39391597
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
2A Pharma ApS (CVR 39391597) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 2,096,492 and a net result of DKK 322,401 compared with DKK -81,364 the year before. That is an increase of 37.4% compared with the year before. Equity in the 2020 report amounted to DKK 666,777. The solvency ratio was 63.2%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 2,096,492
- Profit/Loss
- DKK 322,401
- Equity
- DKK 666,777
- Total Assets
- DKK 1,055,388
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 2.1 mio. | 322 t. | 667 t. | 3 |
| 2019 | - | 1.5 mio. | -81 t. | 344 t. | 1 |
| 2018 | - | 947 t. | -60 t. | 426 t. | 1 |
How creditworthy is 2A Pharma ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
2A Pharma ApS has published its annual report for 2019. Gross profit came to DKK 1,525,401, and the net result was DKK -81,364.
About 2A Pharma ApS
2A Pharma ApS is a Danish company of the type Anpartsselskab based in Aalborg Øst, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Preben Bruun-Nyzell and Josephus Dirk Vestergaard Nieland. The company is owned by 2A Pharma AB. The company has 2 employees (2018). In 2025, the company reported a gross profit of DKK 587,253 and a net result of DKK -712,675 compared with DKK 4,297 the year before. Equity in the 2025 report amounted to DKK 263,490.